General Information

Objectives
At the conclusion of this activity, participants will be able to:

• Report on the current status of the philosophy and methodology of targeted multi-modality therapy
• Analyze the interplay between dose distribution, fractionation and chemical/biological agents. Technological advances in radiation therapy planning and delivery and in basic cancer and normal-tissue biology provides the basis for risk-adapted radiation oncology. The symposium will discuss these developments and explore their potential benefits and hazards.
• Identify the role of functional and molecular imaging in target volume definition, in intra-individual dose prescription and in monitoring the response to radiation therapy.
• Present and discuss the state-of-the-art of bio-effect dose-volume models that use patient-specific normal tissue complication data and corresponding 3D dose volume data.
• Discuss the potential of chemical/molecular prognostic and predictive markers for individual treatment optimization.
• Identify mechanisms, programs and resources to further support and implement the investigational strategies described in the bullet points above.

Call for Abstracts

The deadline for submitting an abstract for the 2009 “8th International Conference on Dose, Time and Fractionation in Radiation Oncology – Theragnostic Approach to Personalized Multimodality Cancer Care”  has now passed. The abstracts are now being collated in preparation for the conference.

A big thank you to everyone who took the time to submit their abstract.


CREDIT

Accreditation Statement
The University of Wisconsin School of Medicine and Public Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The University of Wisconsin School of Medicine and Public Health designates this educational activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education Units
The University of Wisconsin-Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 1.55 continuing education units (CEUs) or 15.5 hours.

CAMPEP
This program has been approved for medical physics continuing education credit by the Commission on Accreditation of Medical Physics Education Programs, Inc. (CAMPEP) <http://www.campep.org/index.html>.

MDCB
This program has been approved for medical dosimetrists continuing education credit by the Medical Dosimetrist Certification Board (MDCB).  All approved MDCB CE activities will now be awarded The American Registry of Radiologic Technologists (ARRT) Category A credit.

Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin School of Medicine and Public Health that the faculty, authors, planners, and other persons who may influence the content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosure will be made in the course handout materials.